189 related articles for article (PubMed ID: 7137357)
1. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
[TBL] [Abstract][Full Text] [Related]
2. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
Yanaura S; Izuka A; Ishikawa S
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
[TBL] [Abstract][Full Text] [Related]
3. Effect of tauroursodeoxycholate feeding, with or without taurine supplementation on hepatic bile acids and cholesterol metabolism in the hamster.
Bellentani S; Bosisio E; Pecorari M; De Fabiani E; Cordoma P; Crestani M; Manenti F
Pharmacol Res Commun; 1987 May; 19(5):327-39. PubMed ID: 3628457
[TBL] [Abstract][Full Text] [Related]
4. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
[TBL] [Abstract][Full Text] [Related]
5. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
[TBL] [Abstract][Full Text] [Related]
6. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R
J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066
[TBL] [Abstract][Full Text] [Related]
7. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
[TBL] [Abstract][Full Text] [Related]
8. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
Ceryak S; Bouscarel B; Malavolti M; Robins SJ; Caslow KL; Fromm H
Atherosclerosis; 2000 Nov; 153(1):59-67. PubMed ID: 11058700
[TBL] [Abstract][Full Text] [Related]
9. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
10. Permeability of the rat biliary tree to ursodeoxycholic acid.
Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
[TBL] [Abstract][Full Text] [Related]
11. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.
Úriz M; Sáez E; Prieto J; Medina JF; Banales JM
PLoS One; 2011; 6(12):e28717. PubMed ID: 22194894
[TBL] [Abstract][Full Text] [Related]
13. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat.
Zouboulis-Vafiadis I; Dumont M; Erlinger S
Am J Physiol; 1982 Sep; 243(3):G208-13. PubMed ID: 7114264
[TBL] [Abstract][Full Text] [Related]
14. Effect of ursodeoxycholic acid administration on bile acid composition in hamster bile.
Matejka M; Vescina C; Carducci CN; Alayón A; Dios A; Scarlatto E; Mamianetti A
Pharmacol Res; 1990; 22(3):297-305. PubMed ID: 2367280
[TBL] [Abstract][Full Text] [Related]
15. Replacement of cholesterol gallstones by murideoxycholyl taurine gallstones in prairie dogs fed murideoxycholic acid.
Cohen BI; Ayyad N; Mosbach EH; McSherry CK; Matoba N; Hofmann AF; Ton-Nu HT; Peng Y; Schteingart CD; Stenger RJ
Hepatology; 1991 Jul; 14(1):158-68. PubMed ID: 2066064
[TBL] [Abstract][Full Text] [Related]
16. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
Lake JR; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
[TBL] [Abstract][Full Text] [Related]
17. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
18. Effect of tauroursodeoxycholic acid (TUDCA) on biliary lipid composition.
Muraca M; Vilei MT; Cianci V; Liu XT
Ital J Gastroenterol; 1995; 27(8):439-40. PubMed ID: 8775471
[TBL] [Abstract][Full Text] [Related]
19. The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition.
Batta AK; Salen G; Shefer S; Tint GS; Dayal B
Hepatology; 1982; 2(6):811-6. PubMed ID: 7141393
[No Abstract] [Full Text] [Related]
20. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Nakagawa M; Colombo C; Setchell KD
Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
